Form 8-K - Current report:
SEC Accession No. 0001104659-21-128982
Filing Date
2021-10-22
Accepted
2021-10-22 16:17:06
Documents
12
Period of Report
2021-10-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2130883d1_8k.htm   iXBRL 8-K 26164
  Complete submission text file 0001104659-21-128982.txt   198494

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nbse-20211022.xsd EX-101.SCH 3222
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbse-20211022_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbse-20211022_pre.xml EX-101.PRE 22735
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2130883d1_8k_htm.xml XML 3500
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 211340736
SIC: 2834 Pharmaceutical Preparations